Latest Insider Transactions at Mednax, Inc. (MD)
This section provides a real-time view of insider transactions for Mednax, Inc. (MD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDNAX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDNAX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2021
|
Waldemar, Md Carlo A Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+11.75%
|
-
|
|
May 12
2021
|
Paul G Gabos Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+14.33%
|
-
|
|
May 12
2021
|
Manuel Kadre Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+3.64%
|
-
|
|
May 12
2021
|
Thomas Mc Eachin |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+22.48%
|
-
|
|
May 12
2021
|
Roger Md Medel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+0.37%
|
-
|
|
May 12
2021
|
Michael A. Rucker |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+19.36%
|
-
|
|
May 12
2021
|
Guy P Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+13.8%
|
-
|
|
May 12
2021
|
John M. Starcher Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+22.49%
|
-
|
|
May 12
2021
|
Shirley A Weis |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+22.1%
|
-
|
|
Apr 01
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
100,000
-3.53%
|
$2,500,000
$25.61 P/Share
|
|
Mar 01
2021
|
Dominic J Andreano EVP, General Counsel and Secy |
BUY
Grant, award, or other acquisition
|
Direct |
55,103
+19.27%
|
-
|
|
Mar 01
2021
|
Roger Mack Hinson Pres., PDX & OBX Medical Group |
SELL
Payment of exercise price or tax liability
|
Direct |
6,244
-4.76%
|
$149,856
$24.43 P/Share
|
|
Mar 01
2021
|
Roger Mack Hinson Pres., PDX & OBX Medical Group |
BUY
Grant, award, or other acquisition
|
Direct |
61,225
+21.18%
|
-
|
|
Mar 01
2021
|
Roger Md Medel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
72,575
-4.87%
|
$1,741,800
$24.43 P/Share
|
|
Mar 01
2021
|
Mark S Ordan |
BUY
Grant, award, or other acquisition
|
Direct |
142,858
+29.9%
|
-
|
|
Mar 01
2021
|
C Marc Richards EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,143
+30.8%
|
-
|
|
Mar 01
2021
|
John C Pepia Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,568
-1.96%
|
$61,632
$24.43 P/Share
|
|
Mar 01
2021
|
John C Pepia Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,409
+7.52%
|
-
|
|
Jan 04
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
100,000
-3.19%
|
$2,300,000
$23.65 P/Share
|
|
Dec 10
2020
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
33,194
-2.04%
|
$763,462
$23.04 P/Share
|
|
Dec 09
2020
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
66,806
-3.95%
|
$1,536,538
$23.0 P/Share
|
|
Jul 31
2020
|
Stephen D Farber Former Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
200,000
-71.94%
|
-
|
|
Jul 24
2015
|
Roger Md Medel Director |
SELL
Bona fide gift
|
Direct |
1,645
-0.1%
|
-
|
|
Jul 20
2015
|
Roger Md Medel Director |
SELL
Bona fide gift
|
Direct |
12,735
-0.75%
|
-
|